• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

MGC Pharma Granted European Medical Cannabis License

June 6, 2017


Earlier this week, MGC Pharmaceuticals Ltd. (ASX:MXC) (OTC:MGCLF) announced the company has obtained a full medical cannabis license through its three-year botanical research partnership with the Biotechnical Faculty of University of Ljubljana in Slovenia. 


The research program aims to develop strains tailored for specific indications including epilepsy, chronic pain, and chemotherapy related side effects. The program will be led by Dr. Jana Murovec, Dr. Marko Flajsman and Professor Borut Bohanec. In order to facilitate the research, the Faculty has been granted a full medical cannabis license from the Slovenian Ministry of Health. 


This partnership expands on MGC Pharmaceuticals previously announced research partnerships with Panax Pharma (5 year breeding license held by their partner university, the Institute of Experimental Botany of the Academy of Sciences of the Czech Republic) and their partnership with the Royal Melbourne Institute of Technology. 


Market Reaction


Since the announcement Monday, shares of MGC Pharmaceuticals are roughly flat after reversing all of Monday's gains in Tuesday's trading on the ASX. Year to date, shares of MGC Pharmaceuticals are also roughly flat, significantly underperforming many of their cannabis related peers on the ASX


View the original ASX announcement here




We're expanding our coverage of the marijuana industry in Australia as well as the European Union. To stay up to date, be sure to subscribe to our free Australian cannabis email newsletter and stay tuned for more coverage of the emerging marijuana industry in the European Union and surrounding countries. Also, don't forget to connect with The Daily Marijuana Observer on FacebookTwitter and Instagram





Please reload

Please reload

Please reload


© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.